August 4, 2016

Break up with Your Makeup + Sweepstakes

Thank you Galderma Laboratories, L.P., the makers of Soolantra® (ivermectin) Cream, 1%, Oracea® (doxycycline, USP) 40 mg* Capsules, and Mirvaso® (brimonidine) Gel, 0.33%**, for sponsoring this post. Vote for your favorite no-makeup selfies here to enter into Galderma’s “Break Up with Your Makeup” sweepstakes for a chance to win one of three $500 gift cards.


What has your makeup done for you lately?  I’ve noticed that the older I get, the more makeup I wear.  But why?  Piling makeup on actually has the opposite effect and makes me look older (and I’m at the age where I definitely don’t want to look older.)  I’ve been guilty myself of trying to mask all my imperfections, but today I am going to be confident in my own skin.  Hiding my skin under all that makeup doesn’t really help the matter; it only hurts it.  I want beautiful healthy skin just like everyone else.  Today, I am going to break up with my makeup.

Today I’m asking you to say goodbye to your concealer and makeup with me by joining the Break Up with Your Makeup campaign.  No matter whether you have rosacea or other skin issues, Galderma Laboratories, L.P. offers a variety of treatments  to help the underlying problem instead of just covering it up like makeup does.  Galderma has three different rosacea treatment options – Soolantra® (ivermectin) Cream, 1%, Oracea® (doxycycline, USP) 40mg* Capsules and Mirvaso® (brimonidine) Gel, 0.33%** – all which can help treat rosacea.  Every time I go to the lake or the pool, I have constantly worried about my makeup washing off exposing my rosy face.  But confidence comes from within, not from the outside.

Will you break up with your makeup?  P.S.  For a chance to win one of three $500 gift cards, make sure you enter the Break Up with Your Makeup Sweepstakes.  What is your biggest skin issue?  What makes you feel most confident?

Important Safety Information for Soolantra® Cream


Indication: SOOLANTRA® (ivermectin) Cream, 1%, is indicated for the treatment of inflammatory lesions of rosacea. Not for oral, ophthalmic or intravaginal use. Adverse Events: In clinical trials with SOOLANTRA Cream, the most common adverse reactions (incidence ≤1%) included skin burning sensation and skin irritation.







Important Safety Information for Oracea® Capsules




Indication: ORACEA® (doxycycline, USP) 40 mg* Capsules are indicated for the treatment of only


inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA Capsules do not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with ORACEA Capsules were nasopharyngitis, sinusitis, diarrhea, hypertension and aspartate aminotransferase increase. Warnings/Precautions: ORACEA Capsules should not be used to treat or prevent infections. ORACEA Capsules should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA Capsules should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years). Although photosensitivity was not observed in clinical trials, ORACEA Capsules patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA Capsules treatment beyond 16 weeks and safety beyond 9 months have not been established.




*30 mg immediate release & 10 mg delayed release beads







Important Safety Information for Mirvaso® Gel


Indication: Mirvaso® (brimonidine) topical gel, 0.33%** is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: MIRVASO Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of MIRVASO Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.




**Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.







You are encouraged to report negative side effects of prescription drugs to the FDA. Visit call 1-800-FDA-1088.




All trademarks are the property of their respective owners.

I was selected for this opportunity as a member of Clever Girls and the content and opinions expressed here are all my own.


1 thought on “Break up with Your Makeup + Sweepstakes”

Leave a Comment

Your email address will not be published. Required fields are marked *





Scroll to Top